HALB Stock News 0.0060 05/08/2014 00:30:22 Halberd Corporation

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Halberd Corporation (HALB) 0.0060 $HALB

Emphysema - Pipeline Review, H2 2013 Research Report
M2 - Fri Feb 14, 2:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/5thttd/emphysema) has announced the addition of the "Emphysema - Pipeline Review, H2 2013" report to their offering. 'Emphysema - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Emphysema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Emphysema. Scope - A snapshot of the global therapeutic scenario for Emphysema. - A review of the Emphysema products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Emphysema pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Emphysema Overview Therapeutics Development Emphysema - Pipeline Products Glance Clinical Stage Products Early Stage Products Unknown Stage Products Icure Pharmaceutical Inc. Emphysema - Therapeutics Assessment Drug Profiles Alpha 1-Proteinase Inhibitor - Drug Profile HI-164OV - Drug Profile Lysine Acetylsalicylate - Drug Profile Alpha-1 Antitrypsin With rHuPH20 - Drug Profile Drug For Emphysema - Drug Profile Retinoic Acid Receptor Agonists - Drug Profile formoterol fumarate Patch - Drug Profile Featured News & Press Releases Companies Mentioned Protalix BioTherapeutics, Inc. Bioxyne Limited Kamada Ltd. Intrexon Corporation Medestea Research & Production S.p.A. Northern Therapeutics, Inc. Icure Pharmaceutical Inc. For more information visit http://www.researchandmarkets.com/research/5thttd/emphysema About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Halberd Corporation Announces Intended Submission of US Government Bid for Wayfinding Kiosks
Marketwire - Wed Aug 07, 7:31AM CDT
Halberd Corporation (PINKSHEETS: HALB) is currently submitting a bid in a full and open competition to procure a US Government contract for an Interactive Wayfinding System that will incorporate Halberd's existing GPS technology at Fort Sam Houston in Houston, TX. Halberd will be constructing and implementing six custom built Wayfinding Kiosks along with interactive GPS software. Halberd will also be required to update the Wayfinding GPS software on a monthly basis along with providing training for the intended users at the Brooke Army Medical Center in Houston, TX.

Halberd Corporation Appoints New Hire
Marketwire - Mon Aug 05, 7:30AM CDT
Halberd Corporation (PINKSHEETS: HALB) announces the hire of Mr. Maurice Sanders. Mr. Sanders comes to Halberd with an extensive background in the computer sciences field and has an impressive work history for almost two decades, including serving four years in the United States Marine Corps.

Halberd Corporation Announces Submission of Source for $7.0M U.S. Government Contract
Marketwire - Thu Jul 25, 7:45AM CDT
Halberd Corporation (PINKSHEETS: HALB) is currently submitting credentials to procure $7.0M US Government contract for application of a Permetherin pesticide mixture to 800+ spruce/pine trees controlling the Epis/pine beetle, located at The Cheyenne VA Medical Center (VAMC). Halberd will utilize a scaled and modified gasoline engine unmanned aircraft system to allow spray calculations, time frame and distance for precision spray application of the Permetherin pesticide mixture. Halberd's UAVs will allow precision spray strokes to cover 100% of trunk circumference until runoff occurs helping minimize waste and potential ground contamination issues.

Halberd Corporation Announces New Commercial Property Search
Marketwire - Mon Jul 22, 3:15PM CDT
Halberd Corporation (PINKSHEETS: HALB) is actively and aggressively seeking out a new office and R&D location for further expansion. In addition to the office and R&D search, Halberd has a variety of highly trained personnel ready to be implemented. With this new location, Halberd will be increasing the sales team along with computer technician personnel who will be trained thoroughly in Halberd's unique unmanned aircraft systems. It's important that Halberd's sales and computer technician teams are knowledgable in the systems they are marketing as well as creating new ideas to improve on existing technology. The goal is for everyone to work together as one, to have Halberd run smoothly and effectively on a daily basis.

Halberd Corporation Announcement for Employment Contract Negotiations
Marketwire - Mon Jul 15, 7:01AM CDT
Halberd Corporation (PINKSHEETS: HALB) is currently in contract negotiations for a Product Development Research position. The prospect has fourteen years experience with the U.S. military, leading and training military personnel in both, Joint Terminal Attach Control and Combat Search and Rescue maneuvers. The prospect has unique specialized training in Remote Pilot Aircraft and Sensor Operations Equipment tactics. We are confident with this new hire, along with other specialized positions, that this strategic move will bring Halberd Corporation to the next level in creative development with our Unmanned Aircraft Systems.

Halberd Corporation Announces New Product Run
Marketwire - Thu Jul 11, 3:15PM CDT
Halberd Corporation (PINKSHEETS: HALB) has engaged in a limited production run of its Coroplast airframe models. These models will be covered in an ultra-light decal material giving the airframe an appearance of being the American Bald Eagle form. The models will be introduced at various air shows throughout the country in conjunction with existing product line demonstrations as a part of the new sales marketing campaign.

Halberd Corporation Announcement Entry Into the Online Consumer Market
M2 - Wed Jun 05, 1:53PM CDT
Company's Low Cost Unmanned Aircraft System Will Be Sold Online Through eBay, RC Universe and Other Online Retailers

Halberd Corporation Appoints New President
M2 - Thu May 30, 8:27AM CDT
LAS VEGAS, NV, May 30, 2013 -- Halberd Corporation (PINKSHEETS: HALB) would like to announce that, effective May 4, 2013, Stacie Allen has accepted the position of President for Halberd Corporation, after Reuben Lowing's termination.

Halberd Corporation Opens Sales and Marketing Location That Also Includes Research and Development Capabilities
Marketwire - Thu Feb 28, 8:30AM CST
Halberd Corporation (PINKSHEETS: HALB) is happy to announce it is opening a new sales and marketing office in Las Vegas. This office will serve as the new corporate headquarters and will combine the sales and marketing staff in one location. In addition to the sales and marketing offices there is expanded room for research and development as well as limited production. Nevada has a superior climate for testing and development of new unmanned systems. The additional flight days allow for shorter development time.

Halberd Corporation Signs Manufacturing Contract
Marketwire - Thu Feb 21, 9:30AM CST
Halberd Corporation (PINKSHEETS: HALB) announces they have entered into an exclusive manufacturing, marketing and distribution contract with Gevers Aircraft Company. The unique patented design of the 'triphibious' airframe gives this high performance aircraft the ability to take off and land on snow, water and land (http://halberdcorp.com/gevers.html). Halberd has additional uses in mind for this airframe that we will elaborate on in the future, but are currently being sought after by various branches of the military. The multipurpose landing gear, telescopic wings and interconnected propeller system provide increased utility, performance, and safety. President Reuben Lowing commented that "As a former Navy Seal I see numerous advantages for this unique configuration as it affords operation on snow, water and land. The US military, especially the Navy Seals will find these abilities superior to our competition. I expect products like this to continue to set us apart from our industry competitors. With our c

Halberd UAS Featured at Alaska Air Carriers Association Symposium
Marketwire - Fri Feb 08, 7:30AM CST
Halberd Corporation (PINKSHEETS: HALB) -- As a result of Halberd Corporation's partnership with the Unmanned Vehicle University we are proud to announce the delivery of its Shadow series airframe on February 13th to UVU, this airframe retails for $14,999.00. This airframe will be showcased at the Alaska Air Carriers Association Symposium in Anchorage, Alaska. The FAA has indicated that Alaska will be the first state approved for commercial UAS systems. UVU in 2012 had 150 students enrolled in the University's Master's and Doctorate programs. Halberd will shortly begin to deliver airframes for their estimated 2013 enrollment of 200 students. Courses from Unmanned Systems Engineering to Unmanned Autonomous Systems will use the Shadow for training and hands on practical use applications. The Shadow series was designed specifically for testing and development of all technologies on a robust and inexpensive airframe without putting at risk expensive airframes.

Halberd Corp Announces Exclusive Partnership With Unmanned Vehicle University to Provide Students a UAV for Research, Engineering and Pilot Training
Marketwire - Thu Feb 07, 7:30AM CST
Halberd Corporation (PINKSHEETS: HALB) has entered into an exclusive agreement with Unmanned Vehicle University (UVU). A cora-plast version of the Halberd Smoke Series(TM) Unmanned Aerial Vehicle (UAV) will be provided to each student in the Doctorate and Masters Degree programs in Unmanned Aircraft Systems Engineering and the Certificate in Unmanned Systems Project Management program. Halberd will be the exclusive provider to UVU's students who will use the UAV for research, engineering and pilot training. "This is an excellent addition to our world class institution that educates and trains future leaders in the commercial unmanned systems industry. This UAV will be integrated with several of our existing courses such as UAV Fundamentals, UAV Aerodynamics and UAV Test and Evaluation to give students important hands-on experience," says Dr. (Col. Ret.) Jerry LeMieux, UVU President.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 273

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 240

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 167

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 0

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 121

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 120

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 184

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 208

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 135

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading

Top 5 Most Recently Viewed Articles

MAAS Embraces Healthcare with Strategic Carve Group Acquisition

Updated Category News Views 117

MAAS Expands into Healthcare and Wellness Maase Inc. (NASDAQ: MAAS) recently announced a significant expansion into the healthcare and wellness sector following its acquisition of Carve Group Ltd. This strategic move signifies MAAS's commitment to innovate within the traditional wellness product landscape by integrating advanced biotechnology. The acquisition is more than...

Continue Reading
Metavesco Welcomes ADHC's Strategic Purchase of OTCfi Tokens

Updated Category News Views 117

Metavesco Celebrates Collaboration with ADHC In a significant development, Metavesco, Inc. (NASDAQ: MVCO) recently expressed excitement over American Diversified Holdings Corporation (NASDAQ: ADHC) announcing their Digital Asset Treasury (DAT) purchase of OTCfi tokens. This partnership is seen as a positive move towards enhancing the visibility and growth of the...

Continue Reading
Understanding Short Interest Trends in Discover Financial

Updated Category News Views 188

Understanding Short Interest Trends in Discover Financial Discover Financial's stock ticker, DFS, has recently experienced an increase in its short interest, rising to 10.94% since the last report. The total number of shares sold short now stands at 3.11 million, equating to 1.42% of the available shares for trading. If we consider the current trading volume, it would...

Continue Reading
Immunic Reaches Key Milestone in Multiple Sclerosis Trials

Updated Category News Views 201

Immunic Completes Enrollment in Phase 3 Trials Immunic, Inc. (NASDAQ: IMUX), a pioneering biotechnology firm, recently reached a significant milestone by completing enrollment for its Phase 3 ENSURE trials, which focus on its lead drug, vidofludimus calcium. These trials target patients living with relapsing multiple sclerosis (RMS) and aim to evaluate the drug's...

Continue Reading
Ergonomic Apparel Revolution: Elevating Back Health in Daily Life

Updated Category News Views 86

Rising Trend of Ergonomic Posture Wear The growing trend of ergonomic apparel highlights the importance of posture-related health concerns. As people spend more time seated and engaged with screens, discomfort is becoming increasingly common. A recent review has brought attention to this phenomenon, shedding light on how ergonomic clothing can play a pivotal role in...

Continue Reading